世界のロミプロスティム市場 2021：企業別、地域別、種類・用途別

• 英文タイトル：Global Romiplostim Market 2021 by Company, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-107A15086 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料では、ロミプロスティムのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。ロミプロスティムの種類別市場規模（250μg/0.5mL、500μg/1mL）、用途別市場規模（成人、小児患者）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・ロミプロスティムの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：AMGEN ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：250μg/0.5mL、500μg/1mL ・用途別分析2016年-2026年：成人、小児患者 ・ロミプロスティムの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・ロミプロスティムのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・ロミプロスティムのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・ロミプロスティムの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・ロミプロスティムの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Romiplostim market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Romiplostim size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Romiplostim market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Romiplostim market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
250 μg/0.5 mL
500 μg/1 mL

Market segment by Application, can be divided into
Adults
Pediatric patients

Market segment by players, this report covers
AMGEN

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

レポート目次

---

1 Market Overview
1.1 Product Overview and Scope of Romiplostim
1.2 Classification of Romiplostim by Type
1.2.1 Overview: Global Romiplostim Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Romiplostim Revenue Market Share by Type in 2020
1.2.3 250 μg/0.5 mL
1.2.4 500 μg/1 mL
1.3 Global Romiplostim Market by Application
1.3.1 Overview: Global Romiplostim Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Adults
1.3.3 Pediatric patients
1.4 Global Romiplostim Market Size & Forecast
1.5 Global Romiplostim Market Size and Forecast by Region
1.5.1 Global Romiplostim Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Romiplostim Market Size by Region, (2016-2021)
1.5.3 North America Romiplostim Market Size and Prospect (2016-2026)
1.5.4 Europe Romiplostim Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Romiplostim Market Size and Prospect (2016-2026)
1.5.6 South America Romiplostim Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Romiplostim Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Romiplostim Market Drivers
1.6.2 Romiplostim Market Restraints
1.6.3 Romiplostim Trends Analysis
2 Company Profiles
2.1 AMGEN
2.1.1 AMGEN Details
2.1.2 AMGEN Major Business
2.1.3 AMGEN Romiplostim Product and Solutions
2.1.4 AMGEN Romiplostim Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 AMGEN Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Romiplostim Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Romiplostim Players Market Share
3.2.2 Top 10 Romiplostim Players Market Share
3.2.3 Market Competition Trend
3.3 Romiplostim Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Romiplostim Revenue and Market Share by Type (2016-2021)
4.2 Global Romiplostim Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Romiplostim Revenue Market Share by Application (2016-2021)
5.2 Romiplostim Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Romiplostim Revenue by Type (2016-2026)
6.2 North America Romiplostim Revenue by Application (2016-2026)
6.3 North America Romiplostim Market Size by Country
6.3.1 North America Romiplostim Revenue by Country (2016-2026)
6.3.2 United States Romiplostim Market Size and Forecast (2016-2026)
6.3.3 Canada Romiplostim Market Size and Forecast (2016-2026)
6.3.4 Mexico Romiplostim Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Romiplostim Revenue by Type (2016-2026)
7.2 Europe Romiplostim Revenue by Application (2016-2026)
7.3 Europe Romiplostim Market Size by Country
7.3.1 Europe Romiplostim Revenue by Country (2016-2026)
7.3.2 Germany Romiplostim Market Size and Forecast (2016-2026)
7.3.3 France Romiplostim Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Romiplostim Market Size and Forecast (2016-2026)
7.3.5 Russia Romiplostim Market Size and Forecast (2016-2026)
7.3.6 Italy Romiplostim Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Romiplostim Revenue by Type (2016-2026)
8.2 Asia-Pacific Romiplostim Revenue by Application (2016-2026)
8.3 Asia-Pacific Romiplostim Market Size by Region
8.3.1 Asia-Pacific Romiplostim Revenue by Region (2016-2026)
8.3.2 China Romiplostim Market Size and Forecast (2016-2026)
8.3.3 Japan Romiplostim Market Size and Forecast (2016-2026)
8.3.4 South Korea Romiplostim Market Size and Forecast (2016-2026)
8.3.5 India Romiplostim Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Romiplostim Market Size and Forecast (2016-2026)
8.3.7 Australia Romiplostim Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Romiplostim Revenue by Type (2016-2026)
9.2 South America Romiplostim Revenue by Application (2016-2026)
9.3 South America Romiplostim Market Size by Country
9.3.1 South America Romiplostim Revenue by Country (2016-2026)
9.3.2 Brazil Romiplostim Market Size and Forecast (2016-2026)
9.3.3 Argentina Romiplostim Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Romiplostim Revenue by Type (2016-2026)
10.2 Middle East & Africa Romiplostim Revenue by Application (2016-2026)
10.3 Middle East & Africa Romiplostim Market Size by Country
10.3.1 Middle East & Africa Romiplostim Revenue by Country (2016-2026)
10.3.2 Turkey Romiplostim Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Romiplostim Market Size and Forecast (2016-2026)
10.3.4 UAE Romiplostim Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Romiplostim Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Romiplostim Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Romiplostim Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Romiplostim Revenue (USD Million) by Region (2016-2021)
Table 5. Global Romiplostim Revenue Market Share by Region (2021-2026)
Table 6. AMGEN Corporate Information, Head Office, and Major Competitors
Table 7. AMGEN Major Business
Table 8. AMGEN Romiplostim Product and Solutions
Table 9. AMGEN Romiplostim Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Global Romiplostim Revenue (USD Million) by Players (2019-2021)
Table 11. Global Romiplostim Revenue Share by Players (2019-2021)
Table 12. Breakdown of Romiplostim by Company Type (Tier 1, Tier 2 and Tier 3)
Table 13. Romiplostim Players Head Office, Products and Services Provided
Table 14. Romiplostim Mergers & Acquisitions in the Past Five Years
Table 15. Romiplostim New Entrants and Expansion Plans
Table 16. Global Romiplostim Revenue (USD Million) by Type (2016-2021)
Table 17. Global Romiplostim Revenue Share by Type (2016-2021)
Table 18. Global Romiplostim Revenue Forecast by Type (2021-2026)
Table 19. Global Romiplostim Revenue by Application (2016-2021)
Table 20. Global Romiplostim Revenue Forecast by Application (2021-2026)
Table 21. North America Romiplostim Revenue by Type (2016-2021) & (USD Million)
Table 22. North America Romiplostim Revenue by Type (2021-2026) & (USD Million)
Table 23. North America Romiplostim Revenue by Application (2016-2021) & (USD Million)
Table 24. North America Romiplostim Revenue by Application (2021-2026) & (USD Million)
Table 25. North America Romiplostim Revenue by Country (2016-2021) & (USD Million)
Table 26. North America Romiplostim Revenue by Country (2021-2026) & (USD Million)
Table 27. Europe Romiplostim Revenue by Type (2016-2021) & (USD Million)
Table 28. Europe Romiplostim Revenue by Type (2021-2026) & (USD Million)
Table 29. Europe Romiplostim Revenue by Application (2016-2021) & (USD Million)
Table 30. Europe Romiplostim Revenue by Application (2021-2026) & (USD Million)
Table 31. Europe Romiplostim Revenue by Country (2016-2021) & (USD Million)
Table 32. Europe Romiplostim Revenue by Country (2021-2026) & (USD Million)
Table 33. Asia-Pacific Romiplostim Revenue by Type (2016-2021) & (USD Million)
Table 34. Asia-Pacific Romiplostim Revenue by Type (2021-2026) & (USD Million)
Table 35. Asia-Pacific Romiplostim Revenue by Application (2016-2021) & (USD Million)
Table 36. Asia-Pacific Romiplostim Revenue by Application (2021-2026) & (USD Million)
Table 37. Asia-Pacific Romiplostim Revenue by Region (2016-2021) & (USD Million)
Table 38. Asia-Pacific Romiplostim Revenue by Region (2021-2026) & (USD Million)
Table 39. South America Romiplostim Revenue by Type (2016-2021) & (USD Million)
Table 40. South America Romiplostim Revenue by Type (2021-2026) & (USD Million)
Table 41. South America Romiplostim Revenue by Application (2016-2021) & (USD Million)
Table 42. South America Romiplostim Revenue by Application (2021-2026) & (USD Million)
Table 43. South America Romiplostim Revenue by Country (2016-2021) & (USD Million)
Table 44. South America Romiplostim Revenue by Country (2021-2026) & (USD Million)
Table 45. Middle East & Africa Romiplostim Revenue by Type (2016-2021) & (USD Million)
Table 46. Middle East & Africa Romiplostim Revenue by Type (2021-2026) & (USD Million)
Table 47. Middle East & Africa Romiplostim Revenue by Application (2016-2021) & (USD Million)
Table 48. Middle East & Africa Romiplostim Revenue by Application (2021-2026) & (USD Million)
Table 49. Middle East & Africa Romiplostim Revenue by Country (2016-2021) & (USD Million)
Table 50. Middle East & Africa Romiplostim Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Romiplostim Picture
Figure 2. Global Romiplostim Revenue Market Share by Type in 2020
Figure 3. 250 μg/0.5 mL
Figure 4. 500 μg/1 mL
Figure 5. Romiplostim Revenue Market Share by Application in 2020
Figure 6. Adults Picture
Figure 7. Pediatric patients Picture
Figure 8. Global Romiplostim Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 9. Global Romiplostim Revenue and Forecast (2016-2026) & (USD Million)
Figure 10. Global Romiplostim Revenue Market Share by Region (2016-2026)
Figure 11. Global Romiplostim Revenue Market Share by Region in 2020
Figure 12. North America Romiplostim Revenue (USD Million) and Growth Rate (2016-2026)
Figure 13. Europe Romiplostim Revenue (USD Million) and Growth Rate (2016-2026)
Figure 14. Asia-Pacific Romiplostim Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. South America Romiplostim Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Middle East and Africa Romiplostim Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Romiplostim Market Drivers
Figure 18. Romiplostim Market Restraints
Figure 19. Romiplostim Market Trends
Figure 20. AMGEN Recent Developments and Future Plans
Figure 21. Global Romiplostim Revenue Share by Players in 2020
Figure 22. Romiplostim Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 23. Global Top 3 Players Romiplostim Revenue Market Share in 2020
Figure 24. Global Top 10 Players Romiplostim Revenue Market Share in 2020
Figure 25. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 26. Global Romiplostim Revenue Share by Type in 2020
Figure 27. Global Romiplostim Market Share Forecast by Type (2021-2026)
Figure 28. Global Romiplostim Revenue Share by Application in 2020
Figure 29. Global Romiplostim Market Share Forecast by Application (2021-2026)
Figure 30. North America Romiplostim Sales Market Share by Type (2016-2026)
Figure 31. North America Romiplostim Sales Market Share by Application (2016-2026)
Figure 32. North America Romiplostim Revenue Market Share by Country (2016-2026)
Figure 33. United States Romiplostim Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 34. Canada Romiplostim Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 35. Mexico Romiplostim Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 36. Europe Romiplostim Sales Market Share by Type (2016-2026)
Figure 37. Europe Romiplostim Sales Market Share by Application (2016-2026)
Figure 38. Europe Romiplostim Revenue Market Share by Country (2016-2026)
Figure 39. Germany Romiplostim Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 40. France Romiplostim Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. United Kingdom Romiplostim Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Russia Romiplostim Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Italy Romiplostim Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Asia-Pacific Romiplostim Sales Market Share by Type (2016-2026)
Figure 45. Asia-Pacific Romiplostim Sales Market Share by Application (2016-2026)
Figure 46. Asia-Pacific Romiplostim Revenue Market Share by Region (2016-2026)
Figure 47. China Romiplostim Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Japan Romiplostim Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. South Korea Romiplostim Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. India Romiplostim Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Southeast Asia Romiplostim Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Australia Romiplostim Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. South America Romiplostim Sales Market Share by Type (2016-2026)
Figure 54. South America Romiplostim Sales Market Share by Application (2016-2026)
Figure 55. South America Romiplostim Revenue Market Share by Country (2016-2026)
Figure 56. Brazil Romiplostim Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Argentina Romiplostim Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Middle East and Africa Romiplostim Sales Market Share by Type (2016-2026)
Figure 59. Middle East and Africa Romiplostim Sales Market Share by Application (2016-2026)
Figure 60. Middle East and Africa Romiplostim Revenue Market Share by Country (2016-2026)
Figure 61. Turkey Romiplostim Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Saudi Arabia Romiplostim Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. UAE Romiplostim Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Methodology
Figure 65. Research Process and Data Source

---